David Sarid
6 Weizmann St, 6423906
Tel Aviv, TA 64239, Israel
Tel Aviv, TA 64239, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: August 30, 2026
Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials.
Journal: Clinical genitourinary cancer
Published: September 06, 2024
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: May 13, 2024
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes.
Journal: JACC. CardioOncology
Published: February 18, 2024
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.
Journal: Nutrients
Published: July 02, 2023
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis.
Journal: Frontiers in oncology
Published: January 27, 2023
Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 25, 2022
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: March 01, 2022
Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 15, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study.
Journal: Nutrients
Published: October 12, 2021
Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection.
Journal: Prostate cancer and prostatic diseases
Published: October 29, 2020
[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
Journal: EJNMMI research
Published: June 13, 2019
Last Updated: 09/26/2026